Evidence map›Paper›PMID 30041491›Full record

ReviewGenes2018

Bioengineering Strategies for Protein-Based Nanoparticles.

Dennis Diaz, Andrew Care, Anwar Sunna

Abstract readReview
In one paragraph

Review in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Drug Delivery Systems for Natural Medicines in Cancer Therapy.Current topics in medicinal chemistry · 2025
    Review
  6. Article
  7. Nanomedicine in Bladder Cancer Therapy.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Antibody therapeutics · 2023
    Article
  14. Article
  15. Review
  16. Virus-inspired strategies for cancer therapy.Seminars in cancer biology · 2022
    Review
  17. Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  18. Article
  19. Review
  20. Systematic studies into uniform synthetic protein nanoparticles.Beilstein journal of nanotechnology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dennis DiazDepartment of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia. dennis.diaz-rincon@hdr.mq.edu.au.
Andrew CareDepartment of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia. andrew.care@mq.edu.au.ORCID 0000-0002-0035-7961
Anwar SunnaDepartment of Molecular Sciences, Macquarie University, Sydney, NSW 2109, Australia. anwar.sunna@mq.edu.au.ORCID 0000-0002-1467-9937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, the practical application of protein-based nanoparticles (PNPs) has expanded rapidly into areas like drug delivery, vaccine development, and biocatalysis. PNPs possess unique features that make them attractive as potential platforms for a variety of nanobiotechnological applications. They self-assemble from multiple protein subunits into hollow monodisperse structures; they are highly stable, biocompatible, and biodegradable; and their external components and encapsulation properties can be readily manipulated by chemical or genetic strategies. Moreover, their complex and perfect symmetry have motivated researchers to mimic their properties in order to create de novo protein assemblies. This review focuses on recent advances in the bioengineering and bioconjugation of PNPs and the implementation of synthetic biology concepts to exploit and enhance PNP's intrinsic properties and to impart them with novel functionalities.

Indexed as

biocatalysisbioengineeringbiomedicinenanobiotechnologynanocagesprotein-based nanoparticlessynthetic biologyvirus-like particle

Identifiers

PMID30041491
PMCPMC6071185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.